Organo Statistics

Total Valuation

Organo has a market cap or net worth of JPY 405.74 billion. The enterprise value is 415.17 billion.

Market Cap	405.74B
Enterprise Value	415.17B

Important Dates

The last earnings date was Friday, November 1, 2024.

Earnings Date	Nov 1, 2024
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Organo has 46.00 million shares outstanding. The number of shares has increased by 0.12% in one year.

Current Share Class	n/a
Shares Outstanding	46.00M
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	25.43%
Float	24.43M

Valuation Ratios

The trailing PE ratio is 20.36 and the forward PE ratio is 19.48.

PE Ratio	20.36
Forward PE	19.48
PS Ratio	2.55
PB Ratio	3.75
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	20.86
EV / Sales	2.61
EV / EBITDA	14.69
EV / EBIT	15.76
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.24.

Current Ratio	2.33
Quick Ratio	2.00
Debt / Equity	0.24
Debt / EBITDA	0.92
Debt / FCF	n/a
Interest Coverage	100.27

Financial Efficiency

Return on equity (ROE) is 19.93% and return on invested capital (ROIC) is 12.56%.

Return on Equity (ROE)	19.93%
Return on Assets (ROA)	9.31%
Return on Capital (ROIC)	12.56%
Revenue Per Employee	63.38M
Profits Per Employee	7.92M
Employee Count	2,512
Asset Turnover	0.91
Inventory Turnover	6.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+59.64%
50-Day Moving Average	7,258.80
200-Day Moving Average	7,391.90
Relative Strength Index (RSI)	63.86
Average Volume (20 Days)	402,355

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Organo had revenue of JPY 159.21 billion and earned 19.91 billion in profits. Earnings per share was 433.18.

Revenue	159.21B
Gross Profit	48.86B
Operating Income	26.17B
Pretax Income	27.77B
Net Income	19.91B
EBITDA	28.10B
EBIT	26.17B
Earnings Per Share (EPS)	433.18

Full Income Statement

Balance Sheet

The company has 16.67 billion in cash and 25.85 billion in debt, giving a net cash position of -9.18 billion or -199.64 per share.

Cash & Cash Equivalents	16.67B
Total Debt	25.85B
Net Cash	-9.18B
Net Cash Per Share	-199.64
Equity (Book Value)	108.49B
Book Value Per Share	2,353.03
Working Capital	86.39B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 30.69%, with operating and profit margins of 16.44% and 12.50%.

Gross Margin	30.69%
Operating Margin	16.44%
Pretax Margin	17.44%
Profit Margin	12.50%
EBITDA Margin	17.65%
EBIT Margin	16.44%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 142.00, which amounts to a dividend yield of 1.62%.

Dividend Per Share	142.00
Dividend Yield	1.62%
Dividend Growth (YoY)	78.38%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.12%
Shareholder Yield	1.49%
Earnings Yield	4.91%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.

Last Split Date	Sep 29, 2022
Split Type	Forward
Split Ratio	4

Scores

Organo has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a